Correction: Direct access to the optically active VAChT inhibitor vesamicol and its analogues via the asymmetric aminolysis of meso-epoxides with secondary aliphatic amines

Org Biomol Chem. 2022 Aug 17;20(32):6473. doi: 10.1039/d2ob90101c.

Abstract

Correction for 'Direct access to the optically active VAChT inhibitor vesamicol and its analogues via the asymmetric aminolysis of meso-epoxides with secondary aliphatic amines' by Arun Sharma et al., Org. Biomol. Chem., 2017, 15, 1913-1920, https://doi.org/10.1039/C6OB02479C.

Publication types

  • Published Erratum